Vericel to Present at Canaccord Genuity and ARM Investor Conferences
March 18 2015 - 8:51AM
Vericel Corporation (Nasdaq:VCEL), a leading developer of
patient-specific expanded cellular therapies for the treatment of
severe diseases and conditions, today announced that it will
present at the following investor conferences later this month:
- Canaccord Genuity Musculoskeletal Conference in Las Vegas on
Tuesday, March 24, 2015; Vericel president and CEO Nick Colangelo
will present a corporate update at 6:00pm EDT with a live webcast
at http://wsw.com/webcast/canaccord17/vcel.
- Alliance for Regenerative Medicine 2015 Regen Med Investor Day
in New York on Wednesday, March 25, 2015; Vericel COO Dan Orlando's
will present a corporate update at 2:40pm EDT with a live webcast
at http://arminvestorday.com/webcast.
About Vericel Corporation
Vericel Corporation (formerly Aastrom Biosciences, Inc.) is a
leader in developing patient-specific expanded cellular therapies
for use in the treatment of patients with severe diseases and
conditions. The company markets two autologous cell therapy
products in the United States: Carticel® (autologous cultured
chondrocytes), an autologous chondrocyte implant for the treatment
of cartilage defects in the knee, and Epicel® (cultured epidermal
autografts), a permanent skin replacement for the treatment of
patients with deep-dermal or full-thickness burns comprising
greater than or equal to 30 percent of total body surface area.
Vericel is also developing MACI™, a third-generation
autologous chondrocyte implant for the treatment of cartilage
defects in the knee, and ixmyelocel-T, a patient-specific
multicellular therapy for the treatment of advanced heart failure
due to ischemic dilated cardiomyopathy. For more information,
please visit the company's website at www.vcel.com.
CONTACT: Chad Rubin
The Trout Group
crubin@troutgroup.com
(646) 378-2947
or
Lee Stern
The Trout Group
lstern@troutgroup.com
(646) 378-2922
Vericel (NASDAQ:VCEL)
Historical Stock Chart
From Mar 2024 to Apr 2024
Vericel (NASDAQ:VCEL)
Historical Stock Chart
From Apr 2023 to Apr 2024